Calcinosis
MONDO:0002123Deposition of calcium in the tissues. It may be the result of a metabolic disorder or long-standing infection, or it may be associated with the presence of cancer.
Also known as: calcification, calcium deposit(s), deposit(s), calcium, macrocalcification, pathologic calcification, pathologically calcified structure
47 clinical trials for this condition and its sub-types, 30 tagged with Calcinosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Calcinosis
-
Calciphylaxis 9 trials
2 sub-types
- Calciphylaxis cutis 0 trials
- Visceral calciphylaxis 0 trials
-
Nephrocalcinosis 7 trials · 8 incl. sub-types
1 sub-type
- Renal hypomagnesemia 3 1 trial
-
Familial tumoral calcinosis 1 trial
5 sub-types
- Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome 0 trials
- Normophosphatemic familial tumoral calcinosis 0 trials
- Tumoral calcinosis, hyperphosphatemic, familial, 1 0 trials
- Tumoral calcinosis, hyperphosphatemic, familial, 2 0 trials
- Tumoral calcinosis, hyperphosphatemic, familial, 3 0 trials
-
New dialysis fluid may slow hardening of arteries in kidney patients
Disease control Not yet recruitingThis study tests whether a citrate-based dialysis fluid with extra magnesium can slow or prevent blood vessel hardening in adults on long-term hemodialysis. Eighty stable patients will receive either the new fluid or a standard one for 12 months. Researchers will measure blood ma…
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for rare, painful skin disease: experimental drug EPN-701 enters phase 2 trial
Disease control Not yet recruitingThis study tests a new drug called EPN-701 for calciphylaxis, a rare condition causing painful skin sores with no approved treatment. About 60 adults with moderate to severe pain and at least one open sore will receive the drug. The main goals are to see if EPN-701 safely reduces…
Phase 2 • Sponsor: Sagar U. Nigwekar, MD, MMSc • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Oxygen chamber therapy put to the test for dozens of diseases
Disease control Not yet recruitingThis study will test hyperbaric oxygen therapy (HBOT) — breathing pure oxygen in a pressurized chamber — for over 30 conditions, including long COVID, Crohn's disease, frostbite, and multiple sclerosis. Researchers will track 100 patients to see if HBOT improves their quality of …
Phase 4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Shockwaves to the neck: new device aims to make artery stenting safer
Disease control Not yet recruitingThis study tests a device that uses sound waves (lithotripsy) to break up calcium buildup in the carotid arteries—the main arteries in the neck—before placing a stent to keep them open. The goal is to see if this approach reduces complications like stroke, heart attack, or death …
Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could an arthritis drug stop a deadly skin condition?
Disease control Not yet recruitingThis trial tests whether tocilizumab, an anti-inflammatory drug, can stop the progression of calciphylaxis—a rare condition where calcium buildup blocks skin blood vessels, causing painful, non-healing wounds. Ten adults with calciphylaxis and end-stage kidney disease will receiv…
Phase 1 • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New combo treatment for Rock-Hard arteries shows promise in clinical trial
Disease control Not yet recruitingThis study compares two methods to treat severely calcified coronary arteries: one uses a special balloon that inflates at very high pressure, and the other combines a rotating burr with sound waves to break up calcium. Researchers will enroll 162 adults with hardened arteries to…
Sponsor: Lin Zhao • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
PET scans may reveal which aortic valves will worsen
Diagnosis Not yet recruitingResearchers at Massachusetts General Hospital are studying whether molecular imaging and detailed biological profiling can predict how quickly aortic stenosis gets worse. The trial enrolls 100 adults with mild to moderate calcific aortic stenosis. Participants receive a baseline …
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Two common drugs put to the test against kidney stones caused by cosmetic paraffin injections
Prevention Not yet recruitingParaffin disease happens when people inject paraffin oil into muscle for cosmetic enlargement, causing chronic inflammation, high blood calcium, kidney stones, and kidney damage. Researchers are testing whether empagliflozin or losartan, two drugs already used for kidney protecti…
Phase 2/3 • Sponsor: Martin Blomberg Jensen • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Are endurance athletes at risk for hidden artery damage?
Knowledge-focused Not yet recruitingThis study will use ultrasound to check for medial arterial calcification (hardening of the arteries) in 60 healthy endurance athletes. The goal is to find out how common this condition is in this group and see if it relates to their training habits or heart risk factors. Partici…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Kidney stone gene mystery: could one faulty copy be enough?
Knowledge-focused Not yet recruitingThis study looks at whether having one or two faulty copies of the CYP24A1 gene makes kidney stones more likely. Researchers will compare people with different gene variants to see how often stones occur. The goal is to better understand the genetic factors behind this common and…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC